Sorafenib controls the epithelial-mesenchymal transition of ovarian cancer cells via EGF and the CD44-HA signaling pathway in a cell type-dependent manner

Park, GB; Ko, HS; Kim, D

Kim, D (reprint author), Inje Univ, Dept Anat, Coll Med, 75 Bokji Ro, Busan 47392, South Korea.

MOLECULAR MEDICINE REPORTS, 2017; 16 (2): 1826